Reham Hammad
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Psoriasis: Treatment and Pathogenesis 3
- Reproductive System and Pregnancy 2
- Immune Cell Function and Interaction 2
- IL-33, ST2, and ILC Pathways 2
- Oncology 4
- Inflammatory Biomarkers in Disease Prognosis 3
- Co-authors
- Nadia Μ. Hamdy (6 shared papers)Claude Lambert (4 shared papers)Mohamed Alboraie (2 shared papers)Sherihan G. AbdelHamid (2 shared papers)Samy Zaky (3 shared papers)Ahmed Elshafei (4 shared papers)Ulrich Sack (3 shared papers)Mohamed Ali (1 shared paper)
In The Last Decade
Reham Hammad
25 papers receiving 332 citations
Peers
Comparison fields: 5 of 51
- Cancer Research 113
- Immunology 53
- Molecular Biology 113
- Oncology 35
- Hepatology 8
Countries citing papers authored by Reham Hammad
This map shows the geographic impact of Reham Hammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reham Hammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reham Hammad more than expected).
Fields of papers citing papers by Reham Hammad
This network shows the impact of papers produced by Reham Hammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reham Hammad. The network helps show where Reham Hammad may publish in the future.
Co-authors
The 25 scholars most cited alongside Reham Hammad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 57 | |
| 2 | 2018 | 49 | |
| 3 | 2023 | 49 | |
| 4 | 2022 | 48 | |
| 5 | 2021 | 23 | |
| 6 | 2022 | 12 | |
| 7 | 2021 | 12 | |
| 8 | 2023 | 11 | |
| 9 | Role of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, Mean Platelet Volume in Egyptian Patients with Psoriasis Vulgaris. | 2020 | 9 |
| 10 | Frequency of Circulating B1a and B2 B-cell Subsets in Egyptian Patients with Type 2 Diabetes Mellitus. | 2018 | 9 |
| 11 | 2021 | 9 | |
| 12 | 2020 | 7 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 2022 | 5 | |
| 16 | The Effect of Low Molecular Weight Heparin in Recurrent Pregnancy Loss: Changes in Radial Uterine Artery Blood Flow and Peripheral Blood NK Cell Fraction. | 2018 | 5 |
| 17 | 2024 | 4 | |
| 18 | Cell Free DNA and CD38 Expression on T helper Cells as Biomarkers of Disease Activity in Rheumatoid Arthritis | 2018 | 3 |
| 19 | 2022 | 3 | |
| 20 | 2022 | 2 |
About Reham Hammad
Reham Hammad is a scholar working on Immunology, Oncology, Cancer Research, Infectious Diseases and Genetics, having authored 27 papers that have together received 333 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (3 papers), Psoriasis: Treatment and Pathogenesis (3 papers), COVID-19 Clinical Research Studies (3 papers), Diabetic Foot Ulcer Assessment and Management (3 papers), Reproductive System and Pregnancy (2 papers), Immune Cell Function and Interaction (2 papers), IL-33, ST2, and ILC Pathways (2 papers) and Musculoskeletal synovial abnormalities and treatments (2 papers). The work is most often cited by research in Cancer Research (113 citations), Immunology (53 citations), Molecular Biology (113 citations), Oncology (35 citations) and Hepatology (8 citations). Reham Hammad has collaborated with scholars based in Egypt, France and Germany. Frequent co-authors include Nadia Μ. Hamdy, Claude Lambert, Mohamed Alboraie, Sherihan G. AbdelHamid, Samy Zaky, Ahmed Elshafei, Ulrich Sack, Mohamed Ali, Eman F. Sanad and Maha Elsabaawy. Their work appears in journals such as International Journal of Molecular Sciences, Innate Immunity, Diabetes Metabolic Syndrome and Obesity, Journal of Diabetes Investigation and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.